Microfluid Platform to Screen Cancer Drug for Delivery

Back to all technologies
Download as PDF
66164
Developing and testing cancer drugs is an expensive process that requires, among other things, exhaustive in vivo animal experiments. One purpose of preclinical animal studies is to analyze how effectively a drug is transported and delivered to its target in a tumor mass. However, animal testing can be an expensive, slow process.

Researchers at Purdue University have developed a microfluidic platform to simulate a 3D tumor vasculature system. This innovative platform can mimic the complex transport processes inside a tumor, such as transvascular transport, interstitial transport, and transmembrane transport. These processes are all simulated on a single benchtop device, thus improving the repeatability and speed of testing, while reducing the cost and use of animals in drug discovery.

Advantages:
-Mimics multiple transport processes
-Increased repeatability and speed for drug testing
-Low cost

Potential Applications:
-Medical/Health
-Pharmaceutical industry
-Drug development
-Research labs

Related Publications:
Bumsoo Han. Physics-inspired micro/nanotherapeutics: Same problem, different approaches. Molecular Pharmaceutics, July 5, 2016, Vol. 13 (7), pp. 2141-2142. DOI: 10.1021/acs.molpharmaceut.6b00482.
May 3, 2013
Utility Patent
United States
9,081,003
Jul 14, 2015

Mar 15, 2013
Provisional-Patent
United States
(None)
(None)

May 3, 2012
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
1801 Newman Road
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org